Development and validation of a new method for visual acuity assesment on tablet in pediatric population: eMOVA test

by Ancé, P., Di Foggia, E., Meunier, H., Moreau, P.-H, Rimele, A., Sauer, A., Speeg-Schatz, C., Stoll, N.
Published 2022

Extramedullary disease in multiple myeloma: a systematic literature review

by Beksac, M., Bladé, J., Caers, J., Jurczyszyn, A., Moreau, P., Rasche, L., Richardson, P., Rosiñol, L., Usmani, S.Z, von Lilienfeld-Toal, M., Zamagni, E.
Published 2022

Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA

by Avet-Loiseau, H., Bahlis, N.J, Cavo, M., Dimopoulos, M.A, Facon, T., Heuck, C., Hungria, V., Iida, S., Kobos, R., Krevvata, M., Kumar, S., Mateos, M.-V, Moreau, P., Munshi, N., Paiva, B., Perrot, A., Plesner, T., Qi, M., San-Miguel, J., Sonneveld, P., Spencer, A., Sun, S., Ukropec, J., Usmani, S.Z, van de Donk, N.W.C.J, Wang, J., Weisel, K.
Published 2022

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

by Anderson, L.D., Jr, Beksac, M., Corso, A., Dimopoulos, M., Dürig, J., Engelhardt, M., Galli, M., Grote, L., Jenner, M., Jiang, R., Kanate, A.S, Larocca, A., Liberati, A.M, Lindsay, J., Moreau, P., Oriol, A., Pavic, M., Peluso, T., Richardson, P.G, Robak, P., Rodriguez-Otero, P., Salomo, M., Schjesvold, F., Sonneveld, P., Vural, F., Weisel, K., White, D., Yagci, M.
Published 2022